Catalyst Pharmaceuticals Inc.
07/16/2026 | Press release | Distributed by Public on 07/17/2026 04:03
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 |
| Accession Number: | 0001193125-26-305088 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Catalyst Pharmaceuticals Inc. published this content on July 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 17, 2026 at 10:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]